Overcoming Immunotherapy Resistance Pathways in the Tumor Microenvironment


Dr. Thomas F. Gajewski, professor of medicine, explains why T cell-inflamed tumor microenvironment may serve as a predictive biomarker for response to immunotherapies.  Dr. Gajewski also describes how STING agonists may provide means to deliberately initiate innate immune inflammation to promote an endogenous T cell response in non-T cell-inflamed tumors.  



Thomas Gajewski

Thomas Gajewski, MD

Professor of Medicine

Admissions, Referrals and Consultations:

Call UCM Physician Connect at
Contact Us